Perceptive David Herron

Calyx and Invicro unveil new identity as Perceptive

The merger of Calyx and Invicro has culminated in the launch of a new corporate entity, Perceptive, marking a significant development in the biopharmaceutical services sector. This rebranding reflects the organisation’s enhanced capabilities in providing comprehensive support throughout the drug development lifecycle.

Norgine van der Kamp

Norgine appoints new CEO to lead next phase of growth

Norgine, a prominent European specialty pharmaceutical and consumer healthcare company, has announced a significant leadership change with the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective 1 January 2025. This move comes as part of the company’s strategy to enhance its mission of delivering transformative medicines to patients and […]

Fraunhofer drug process

Fraunhofer researchers develop streamlined method for pharmaceutical production

A team of interdisciplinary researchers from the Fraunhofer-Gesellschaft has unveiled a new method for producing fine chemicals, including those used in pharmaceuticals, potentially transforming the traditionally complex and labour-intensive manufacturing process. The novel approach, modelled on a cascade system, allows multiple successive stages of synthesis to proceed without interruption, offering significant improvements in efficiency and […]

CRDSA data

New standards aim to enhance clinical trial data sharing and reuse

The Clinical Research Data Sharing Alliance (CRDSA) has released two new standards aimed at improving the sharing and reuse of anonymised individual patient data from clinical trials. The standards, published on 26 September 2024, seek to address common challenges faced by both data contributors and researchers in areas such as metadata, data completeness and utility.

Mount Sinai kiNet kinase

Mount Sinai launches KiNet portal for kinase-substrate interaction analysis

New York-based researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to explore kinase-substrate interactions in human cellular systems. The portal, which aggregates data from multiple public databases, aims to provide the scientific community with a comprehensive platform for visualising and studying these interactions in systemwide […]

Bruker timsTOF Ultra2

NIH grant boosts single-cell mass spectrometry capabilities at JAX Cancer Centre

The Jackson Laboratory (JAX) in Maine, USA, has received a $1.6 million grant from the National Institutes of Health (NIH) to acquire a state-of-the-art mass spectrometry system. This new equipment, the Bruker timsTOF Ultra2, will significantly enhance the institution’s ability to conduct detailed analyses of proteins and metabolites at the single-cell level.

AzentaGenomics A

Azenta to provide proteomics profiling for Finnish personalised medicine project

The FinnGen project, a large-scale Finnish research initiative in personalised medicine, has announced a collaboration with Azenta, Inc. to provide proteomics profiling for up to 20,000 individuals. This partnership aims to integrate proteomic insights with existing genomic data, with the aim advancing our understanding of complex diseases and paving the way for more targeted treatments.

Exothera cedric volanti

Exothera appoints new CEO to lead viral vector and nucleic acid production

Exothera, a GMP-certified contract development and manufacturing organisation (CDMO) specialising in viral vectors, RNA therapeutics, and vaccines, has announced the appointment of Cédric Volanti as its new Chief Executive Officer. The appointment, effective 8 October 2024, marks a significant milestone for the Belgian company as it seeks to strengthen its position in the biopharmaceutical manufacturing […]

FUJIFILM Yutaka

Fujifilm Irvine Scientific expands life sciences portfolio, integrates key products from Fujifilm Wako Chemicals

Fujifilm Irvine Scientific, a provider of cell culture solutions for life science and medical markets, has announced an expansion of its product portfolio through alignment with its sister company, Fujifilm Wako Chemicals U.S.A., Corp. From 1 October 2024, Fujifilm Irvine Scientific will directly promote products from three divisions of Fujifilm Wako Chemicals –Lab Automation, Lab […]

Beckman Coulter BMA

Beckman Coulter and Scopio Labs expand partnership to include digital bone marrow analysis

Beckman Coulter, a prominent clinical diagnostics company, and Scopio Labs, a MedTech firm specialising in digital cell morphology solutions, have announced an expansion of their long-term partnership. The new agreement includes global distribution of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application, which is CE-Marked for use with Scopio’s X100 and X100HT scanners.